Semaglutide addresses the insulin resistance underlying PCOS-related weight gain by improving how your pancreas responds to glucose and reducing appetite signals
Research chemical market availability Where tesofensine is sold: Research chemical websites Some peptide vendors Underground bodybuilding suppliers International sources (China, India) Gray market online pharmacies Typical product offerings: Capsules: 0.25mg, 0.5mg, 1.0mg Powder (raw): 1g, 5g, 10g Solutions (rare) Usually sold in monthly supplies "Research use only" disclaimer Pricing: 0.5mg capsules: $2-5 per capsule Monthly supply (30 0.5mg): $60-150 Cheaper than pharmaceutical GLP-1s ($1,000+) More expensive than generic weight loss meds Price varies widely by vendor Quality and purity concerns: No FDA oversight (research chemicals) Testing varies by vendor Some provide COA (certificate of analysis) Purity ranges 95-99% (claimed) Contamination possible Dosing accuracy uncertain Vendor reputation critical: Established peptide vendors safer Third-party testing important User reviews helpful Avoid unknown sources Higher price often indicates quality Legal risks and considerations Possession risks: Technically legal in most places (not scheduled) "Research use only" provides legal cover Personal use rarely prosecuted No case law establishing precedent Gray area = uncertain legal standing Import/customs risks: International orders may be seized Customs may confiscate as unapproved drug Usually no legal consequences (just loss) Domestic sources lower risk Small quantities for personal use typically okay Selling/distribution risks: Illegal to sell for human consumption FDA enforcement on sellers, not buyers "Research chemical" label required Cannot market for weight loss Vendors face legal risks Medical/insurance implications: No insurance coverage (not approved) Can't get prescription legally Discussing with doctor may cause concerns Medical records implications Self-medicating risks acknowledged Ethical considerations: Using unapproved drug without oversight Risks to self (informed consent?) Supporting gray market industry Alternative FDA-approved options available Safety vs access debate Learn about peptide legality and finding therapy clinics
The protocol of this investigation has been permitted by the Research Ethics Committee (Faculty of Pharmacy, Cairo University) with approval number PT (2963)
Semaglutide and tirzepatide are not recommended in patients with severe gastroparesis (when the stomach empties food into the small intestine too slowly)
If you're picking up an item, ensure you meet in a public place: Never meet with a seller in a secret and lonely place
